Blueprint Medicines Corporation

Historical 13F Holders

Symbol
BPMC
CUSIP
09627Y109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09627Y109 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 8.0% 4/23/2025
Event 3/31/2025
Pentwater Capital Management LP 13G
6.0% 8/14/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Wellington Management Group LLP 13G/A
4.8% 5/12/2025
Event 3/31/2025
FMR LLC 13G/A
3.5% 2/12/2025
Event 12/31/2024
Price T Rowe Associates Inc /MD/ 13G/A 2.3% 8/14/2025
Event 6/30/2025
Avoro Capital Advisors LLC 13G/A
0.6% 8/14/2025
Event 6/30/2025
Davidson Kempner Capital Management LP 13G
0% 7/21/2025
Event 7/14/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $129.00
2026 Q1 2 301 $38.6 k
2025 Q4 2 25.9 k $2.57 M
2025 Q3 5 26.1 k $2.58 M
2025 Q2 390 67.5 M $8.66 B
2025 Q1 381 69.4 M $6.14 B
2024 Q4 375 67.2 M $5.86 B
2024 Q3 355 66.7 M $6.17 B
2024 Q2 342 69.2 M $7.45 B
2024 Q1 323 70.6 M $6.70 B
2023 Q4 296 68.8 M $6.35 B
2023 Q3 243 64.9 M $3.26 B
2023 Q2 243 63.8 M $4.03 B
2023 Q1 236 63.6 M $2.86 B
2022 Q4 244 65.6 M $2.87 B
2022 Q3 251 63.1 M $4.16 B
2022 Q2 257 63.3 M $3.20 B
2022 Q1 265 59.9 M $3.83 B
2021 Q4 298 59.2 M $6.34 B
2021 Q3 303 59.7 M $6.14 B
2021 Q2 293 58.6 M $5.16 B
2021 Q1 276 58.5 M $5.69 B
2020 Q4 304 58.2 M $6.53 B
2020 Q3 258 57.3 M $5.30 B
2020 Q2 258 56.4 M $4.40 B
2020 Q1 240 55.4 M $3.24 B
2019 Q4 251 51.4 M $4.12 B
2019 Q3 245 53.0 M $3.90 B
2019 Q2 247 49.8 M $4.70 B
2019 Q1 222 48.8 M $3.91 B
2018 Q4 178 46.2 M $2.49 B
2018 Q3 210 46.3 M $3.61 B
2018 Q2 200 45.2 M $2.87 B
2018 Q1 190 43.8 M $4.01 B
2017 Q4 181 42.8 M $3.23 B
2017 Q3 144 36.3 M $2.53 B
2017 Q2 131 35.9 M $1.81 B
2017 Q1 144 34.8 M $1.39 B
2016 Q4 110 26.1 M $733 M
2016 Q3 92 19.2 M $569 M
2016 Q2 82 19.5 M $395 M
2016 Q1 73 17.9 M $323 M
2015 Q4 78 18.0 M $474 M
2015 Q3 72 24.3 M $518 M
2015 Q2 70 23.2 M $611 M